Will Trump Presidency Spell Big Changes for the FDA?
- Last Updated: August 4th, 2023
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Will Trump Presidency Spell Big Changes for the FDA?
The Trump Administration and a Republican-led Congress ushers in a new era that will no doubt affect the FDA in terms of leadership, how regulations will be enforced, or if the rules will be scaled back or scrapped entirely.
It has been just one year since Dr. Robert Califf became the chief of the U.S. Food and Drug Administration, but the agency is no doubt in for a post-election shakeup.
Between a Trump presidency and a pro-business Congress, the next few years might bring about deregulation, and with it the end of numerous consumer protections.
Table of Contents
The Drug and Device Industry
The FDA has long walked the line between patient protection and pressure from the pharmaceutical industry for quicker approvals of drugs and medical devices.
Over the last several years, lawmakers have fought over a myriad of bills that would clear the way for a major change in the way the U.S. prescription drugs and medical devices.
President Trump is likely to enable the pharmaceutical industry to get much of what it wants in terms of deregulation.
Tobacco Regulation
In 2016, long-awaited federal rules to put the regulation of all tobacco products, including e-cigarettes, under the authority of the U.S. Food and Drug Administration (FDA) finally became official.
Prior to the Electronic Nicotine Delivery System rules, E-Cigarettes have been virtually unsupervised by the government.
But on his fifth day in office, President Trump received a letter from Rep.
Duncan Hunter (R-Calif.), asking him to repeal, or at least delay, the new rules.
Hunter is asking Trump to consider repealing or suspending the rule or at a minimum move the filing deadline for new products back two years, from August 8, 2018, to August 8, 2020.
Farm and Food Production
Trump has previously expressed intent to overhaul FDA programs that govern farm and food production, and Congress could cut the agency’s budget, making it difficult or even impossible to fund programs to prevent food-borne infections, prevent misleading food labels, and keep unsafe additives out of the food supply.
However, the Food, Drug, and Cosmetic Act cannot be altered with an executive order, and President Trump may undoubtedly find out that there are limits to what he can really do.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
